If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCranswick Regulatory News (CWK)

Share Price Information for Cranswick (CWK)

Share Price is delayed by 15 minutes
Get Live Data
5,580.00    -50.00 (-0.89%)
Bid:
5,580.00
Ask:
5,590.00
Spread: 10.00 (0.179%)
Market Cap: £2.99b
CWK Live PriceLast checked at - London Stock Exchange

Intraday Cranswick Share Chart

Director/PDMR Shareholding

3 Aug 2018 12:21

RNS Number : 8022W
Cranswick PLC
03 August 2018
 

Director/PDMR Shareholding

Cranswick plc ("the Company")

The Company has been notified that the following award of LTIP nil-cost options has been made, pursuant to the Cranswick plc Long Term Incentive Plan (the "Scheme"), to certain Directors/Persons Discharging Managerial Responsibility ("PDMR") over ordinary shares of 10 pence each in the Company ("Ordinary Shares"), as follows:

Name

No. of Ordinary Shares subject to Option

Martin Davey

19,100

Adam Couch

38,600

Mark Bottomley

25,500

Jim Brisby

25,500

Chris Aldersley

15,800

The nil-cost options were granted on 1 August 2018 in accordance with the Scheme and are based on a share price of 3293.34 pence per Ordinary Share, being the average quoted market price of the Company's shares on the three dealing days prior to the date of grant.

Each person has also been granted a tax qualifying option over 910 Ordinary Shares at an exercise price of 3293.34 pence per Ordinary Share as part of their award. These tax qualifying options are linked to the LTIP nil-cost options such that, at the time of exercise, to the extent that there is a gain in the tax qualifying option, the LTIP nil-cost option will be forfeited to the value of that gain.

Vesting of the LTIP nil-cost options and tax qualifying options is subject to the achievement of the performance criteria based on growth in EPS (as regards 50% of the awards) and relative Total Shareholder Return (as regards 50% of each award). The targets applying to each element are as follows.

 

Target

EPS

Threshold

Average annual % growth in RPI + 3%

Maximum

Average annual % growth in RPI + 9%

TSR

Threshold

Median

Maximum

Upper decile

 

Enquiries:

Steven Glover, Company Secretary tel: 01482 372000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHEAFPDEAEPEFF
Date   Source Headline
25th Mar 20254:12 pmRNSDirector/PDMR Shareholding
24th Mar 20253:39 pmRNSDirector/PDMR Shareholding
20th Mar 20257:00 amRNSCMD and upgraded medium term targets
11th Mar 20257:05 amRNSDirectorship
5th Mar 20252:24 pmRNSTotal Voting Rights
3rd Mar 20253:27 pmRNSHolding(s) in Company
24th Feb 20254:54 pmRNSDirector/PDMR Shareholding
10th Feb 20252:51 pmRNSAdditional Listing
3rd Feb 202510:04 amRNSTotal Voting Rights
22nd Jan 20251:21 pmRNSHolding(s) in Company
21st Jan 20257:00 amRNSQ3 Trading Update and Acquisition of JSR Genetics
7th Jan 20254:02 pmRNSTotal Voting Rights
27th Dec 20247:00 amRNSDirector/PDMR Shareholding
11th Dec 20243:26 pmRNSHolding(s) in Company
3rd Dec 20249:53 amRNSTotal Voting Rights
26th Nov 20247:00 amRNSINTERIM RESULTS
13th Nov 202411:41 amRNSTotal Voting Rights
1st Oct 202412:46 pmRNSTotal Voting Rights
1st Oct 202412:43 pmRNSBlock Listing LTIP return
1st Oct 202412:41 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Oct 202412:38 pmRNSDirector/PDMR Shareholding
27th Sep 20247:00 amRNSHalf Year Trading Update
25th Sep 20243:19 pmRNSDirector/PDMR Shareholding
16th Sep 202411:56 amRNSHolding(s) in Company
16th Sep 202411:55 amRNSHolding(s) in Company
12th Aug 202412:15 pmRNSDirector/PDMR Shareholding
6th Aug 20244:20 pmRNSDirector/PDMR Shareholding
5th Aug 202412:18 pmRNSDirector/PDMR Shareholding
5th Aug 202412:16 pmRNSDirector/PDMR Shareholding
5th Aug 202412:15 pmRNSDirector/PDMR Shareholding
5th Aug 202412:11 pmRNSDirector/PDMR Shareholding
1st Aug 202410:52 amRNSTotal Voting Rights
29th Jul 20244:02 pmRNSAGM Statement
29th Jul 20247:00 amRNSFirst quarter trading statement
3rd Jun 20249:42 amRNSTotal Voting Rights
21st May 20247:00 amRNSPreliminary Results
15th May 20245:22 pmRNSDirector/PDMR Shareholding
2nd May 20249:26 amRNSTotal Voting Rights
2nd Apr 20241:55 pmRNSBlock listing Interim Review
2nd Apr 20241:54 pmRNSBlock listing Interim Review
2nd Apr 20241:50 pmRNSTotal Voting Rights
27th Mar 20249:58 amRNSDirector/PDMR Shareholding
21st Mar 20241:57 pmRNSDirector/PDMR Shareholding
21st Mar 20241:55 pmRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSDirectorate Change
15th Mar 20243:58 pmRNSDirector/PDMR Shareholding
4th Mar 20249:58 amRNSTotal Voting Rights
14th Feb 202410:11 amRNSDirector/PDMR Shareholding
14th Feb 202410:11 amRNSDirector/PDMR Shareholding
2nd Feb 202411:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.